Yair Goldberg
Overview
Explore the profile of Yair Goldberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2901
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woodbridge Y, Mandel M, Goldberg Y, Huppert A
Stat Med
. 2025 Feb;
44(5):e70033.
PMID: 39995297
Viral load (VL) in the respiratory tract is the leading proxy for assessing infectiousness potential. Understanding the dynamics of disease-related VL within the host is of great importance, as it...
2.
Madmon O, Goldberg Y
Epidemics
. 2024 Dec;
50:100811.
PMID: 39708556
Over three years since the first identified SARS-CoV-2 case was discovered, the role of adolescents and children in spreading the virus remains unclear. Specifically, estimating the relative susceptibility of a...
3.
Di Domenico L, Goldberg Y, Colizza V
Infect Dis Model
. 2024 Oct;
10(1):150-162.
PMID: 39380724
As public health policies shifted in 2023 from emergency response to long-term COVID-19 disease management, immunization programs started to face the challenge of formulating routine booster campaigns in a still...
4.
Zychlinski N, Fluss R, Goldberg Y, Zubli D, Barkai G, Zimlichman E, et al.
PLoS One
. 2024 Aug;
19(8):e0309077.
PMID: 39159148
Background: Hospital-at-home (HAH) is increasingly becoming an alternative for in-hospital stay in selected clinical scenarios. Nevertheless, there is still a question whether HAH could be a viable option for acutely...
5.
Levine S, Goldberg Y, Rotstein A, Samara M, Yoshida K, Cipriani A, et al.
Eur Psychiatry
. 2024 Feb;
67(1):e19.
PMID: 38389390
Background: A short yet reliable cognitive measure is needed that separates treatment and placebo for treatment trials for Alzheimer's disease. Hence, we aimed to shorten the ' (ADAS-Cog) and test...
6.
Woodbridge Y, Goldberg Y, Amit S, Kopelman N, Mandel M, Huppert A
Sci Rep
. 2024 Jan;
14(1):1430.
PMID: 38228695
During the Covid-19 pandemic, accurate PCR tests were augmented by the cheap, rapid, and logistically convenient, yet less sensitive antigen tests. In Israel, a testing policy shift was implemented due...
7.
Goldberg Y, Huppert A
Lancet Respir Med
. 2023 Oct;
11(12):1039-1041.
PMID: 37898149
No abstract available.
8.
Goldberg Y, Amir O, Mandel M, Freedman L, Bar-On Y, Bodenheimer O, et al.
J Clin Epidemiol
. 2023 Sep;
163:111-116.
PMID: 37774957
Objectives: This study aims to address limitations in assessing vaccine protection using the classical vaccine effectiveness (VE) measure, especially in contexts where a significant portion of the population is already...
9.
Amir O, Goldberg Y, Mandel M, Bar-On Y, Freedman L, Bodenheimer O, et al.
Int J Epidemiol
. 2023 May;
52(5):1299-1302.
PMID: 37244650
No abstract available.
10.
Amir O, Goldberg Y, Mandel M, Bar-On Y, Bodenheimer O, Freedman L, et al.
Commun Biol
. 2023 Mar;
6(1):315.
PMID: 36959496
Following evidence of waning immunity against both infection and severe disease after 2 doses of the BNT162b2 vaccine, Israel began administering a 3rd BNT162b2 dose (booster) in July 2021. Recent...